• Non ci sono risultati.

78

Bibliografia

1

Mastroiacovo P, Baronciani D, Bortolus R. Prevenzione primaria degli esiti avversi della riproduzione attraverso la promozione della salute preconcezionale. Quaderni ACP, 2010

2

Chamberlain G. The prepregnancy clinic. Br Med J 1980

3

Morrell MJ. Guidelines for the care of women with epilepsy. Neurology 1998

4

Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981

5

Czeizel A, Rode K. Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet 1984

6

Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992

7

Scala I, Matroiacovo P, Bortolus R Acido Folico che cosa è, a che cosa serve. Prospettive in Pediatria 2008

8

Shah Ps, eta al. Intention to become pregnant and low birth weight and preterm birth: a systemiv review. Matern Child Health 2009

9

Kost K, et al. The effects of pregnancy planning status on birth outcomes and infant care. Fam Plann Perspect 1998

10

chu SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes care. 2007

12

Stothard Kj, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009

12

Lam PK, Brand RJ. A low pregnancy body mass index is a risk factor for an offspring with gastroschisis. Epidemiology. 1999

13

Vujkovic M, de Vries JH, Lindemans J, Macklon NS, van der Spek PJ, Steegers EA, Steegers-Theunissen RP. The preconception Mediterranean dietary pattern in couples undergoing in vitro fertilization/intracytoplasmatic sperm injection treatment increases the chance of pregnancy. Fertil Steril. 2010

14

Vujkovic M, Steegers EA, Looman CW, Ockè MC, van der Spek PJ, Steegers-Theunissen RP. The maternal Mediterranean dietary pattern is associated with a reduced risk of spina bifida in the offspring. BJOG. 2009

79

15

Obermann-Borst S, Vujkovic M, de Vries J, Wildhagen M, Looman C, de Jonge R, Steegers E, Steegers-Theunissen R. A maternal dietary pattern characterized by fish and seafood in association with the risk of congenital heart defects in the offspring. BJOG. 2011

16

EUROCAT. Special report. Prevention of neural tube defects by periconceptional folic acid supplementation in Europe. 2009

17

Lumley J, et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Syst Rev 2001

18

MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the MRC Vitamin Study. Lancet 1991

19

Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LC, Gindler J, Hong S, Correa A, for the China-US Collaborative Project for Neural Tube Defect Prevention. Prevention of neural defects with folic acid in China. N Eng J Med 1999

20

Mathews TJ, et al. Spina bifida and anencephaly prevalence--United States, 1991-2001. MMWR Recomm Rep 2002

21

Persad VL, et al. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002

22

Ray JG, et al. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002

23

Castilla EE, et al. Latin American Collaborative Study of Congenital Malformations (ECLAMC). Preliminary data on changes in NTD after folic acid fortification. Am J Med Genet 2003;

24

Chen LT, et al. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev 2004

25

Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet 2004

26

Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 2004;62:S3-12

27

Mastroicavo P, et al. La prevenzione delle malformazioni congenite, Medico e Bambino 1998

28

Saggese G, Vierucci F: Vitamina D: perché, quando, come. Pediatria preventiva & sociale 2009

29

Little J, et al. Tobacco smoking and oral clefts: a meta analysis. Bull World Health Organ 2004

80

30

Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med. 1999

31

Lumley J, Oliver SS, Chamberlain C, Oakley K.: Interventions for promoting smoking cesssation during pregnancy. Cochrane Database Issue 2, 2004

32

Floyd RL, et al. Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med 2007

33

Kuczkowski KM. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol. 2007

34

Buhimshi CS, et al Medications in pregnancy and lactiation. Teratology 2009

35

De Santis M, et al. Radiation effects on development. Birth defects Res C Embryo Today 2007

36

Seely EW, et al. Chronic hypertension in pregnancy. N Eng J Med 2011

37

Zaw W, Stone DG. Caudal regression syndrome in twin pregnancy with type II diabetes. J Perinatol 2002

38

Aberg A, Westbom L, Kallen B. Congenital Malformations among infants whose mothers had gestational diabetes or pre-existing diabetes. Early Human Develop 2001

39

Sheffield JS, Butler-Koster, Casey BM, McIntire DD, Leveno KJ. Maternal diabetes and infants malformations. Obstet Gynecol 2002

40

Sharpe PB, Chan A, Haan EA, Hiller JE. Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. Birth defects Res 2005

41

Melamed N, Chen R, Soiberman U, Ben-Haroush A, Hod M, Yogev Y. Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors. Arch Gynecol Obstet. 2008

42

Ray et al. Preconception care and risk of congenitl anomalies in the offspring of women with diabetes mellitus: a meta analysis. Q J Med 2001

43

Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Mat Fet Med 2000

44

Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 2000

45

Allen VM, et al. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can. 2007

46

Viinikainen K, Heinonen S, Eriksson K, Kalviainen R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006

81

47

Meador KJ, et al. In utero antiepileptic drug exposure:fetal death and malformations. Neurology 2006

48

Kalviainen R, et al. Optimizing treatment of epilepsy during pregnancy. Neurology 2006

49

Tomson T, Hiilesmaa V. Epilepsy in pregnancy. BMJ. 2007

50

Clarkson P, James A. Parenteral vitamin K: the effective prophylaxis against haemorrhagic disease for all newborn infants. N Z Med J 1990;103:95–6.

51

Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12:63–68

52

Garntner R, et al. Thyroid diseases in pregnancy. Curr Opin Obstet Gynecol 2009

53

Glinoer D. Management of hypo- and hyperthyroidism during pregnancy. Growth Horm IGF Res 2003

54

Spong CY. Subclinical hypothyroidism: should all pregnant women be screened? Obstet Gynecol 2005

55

Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007

56

Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol 1988

57

Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1999

58

Montoro M, Collea JV, Frasier SD, Mestman JH. Successful outcome of pregnancy in women with hypothyroidism. Ann Intern Med 1981

59 Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O’Heir CE,

Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999

60

den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP The relation between neonatal thyroxine levels and neurodevelopmental outcome at 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996

61

Mandel SJ, et al. Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: maternal aspects. Best Pract Res Clin Endocrinol Metab 2004

62

Brent GA Maternal hypothyroidism: recognition and management. Thyroid 1999

63

Glinoer D, et al. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997

82

64

Mandel SJ, Larsen PR, Seely EW, Brent GA Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1999

65

Glinoer D, et al. Thyroid hyperfuction during pregnancy. Thyroid 1998

66

Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 2004

67

Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J, Lejeune B. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990

68

Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;

69

Peleg D, Cada S, Peleg A, Ben-Ami M. The relationship between maternal serum thyroid- stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 2002

70

Radetti G, Zavallone A, Gentili L, Beck-Peccoz P, Bona G. Fetal and neonatal thyroid disorders. Minerva Pediatr 2002

71

Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. Antithyroid drug therapy for Graves’ disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986

72

Margetic S. Diagnostic algorithm for thrombophilia screening. Clin Chem Lab Med 2010

73

Bates SM,et al. Venous thromboembolis, thrombophlia, antitrombotic therapy and pregnancy. Guidelines American College of Chest Physicians 2008

74

Linee guida regione Liguria per test per trombofilie.

75

Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002

76

Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J, Hamersley SL, Hyers TM, Katz V, Kuhlmann R, Nutescu EA, Thorp JA, Zehnder JL; Pregnancy and Thrombosis Working Group. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and advers pregnancy outcomes. Am J Obstes Gynecol.2007

77

De Man YA, Hazes JM, van de Geijn FE, Krommenhoek C, Dolhain RJ. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum 2007

78

Yan Z, Lambert NC, Ostensen M, Adams KM, Guthrie KA, Nelson JL. Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis. Arthritis Rheum 2006

83

79

De Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Diseas Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008

80

Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005

81

Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008

82

Khairy P, eta l. Pregnancy outcomes in women with congenital heart disease. Circulation 2006

83

Vidaeff AC, et al. Pregnancy in women with renal disease, Am J Perinatol 2008

84

Field T, Diego M, Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: a review. Infant Behav Dev. 2006

85

Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gyncecologists. Obstet Gynecol. 2009

86

Joao Monteriro de Pina-Neto Genetic Counseling, J Pediatr (Rio J). 2008

87

Sauerbrei A, et al Herpes simplex and varicella-zoster virus inections during pregnancy: current concepts of prevention, diagnosis and therapy. Med Microbiol Immunol. 2007

88

American Academy of Pediatrics. Varicella Zoster Infections 2006

89

Giambi, et al Allarme Rosolia: promuovere gli interventi per vaccinare le donne suscettibili in età fertile. Ist Super Sanità 2008

90

American Academy of Pediatrics.Rubella 2006

91

Jones J, et al Congenitali Toxoplasmosis. Am Fam Physician 2003

92

Gollub EL, et al Effectiveness of health education on Toxoplasma related knowledge, behaviour, and risk of seroconversion in pregnancy. EUROTOXO 2008

93

Adler SP, et al. Cytomegalovirus Infections. Pediatr Rev 2007

94

Linee guida nazionali SIN 2012

95

Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006

96

de Ruiter A, et al. Guidelines for management of HIV infection in pregnant women 2008

97

Linee guida nazionali SIN 2012

98

Documenti correlati